CIK 0001020214
- Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680262011
- Phone
- +1 925-288-6000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- 4 Exercise or conversion Chief Commercial Officer acquired 3,750 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Commercial Officer acquired 18,750 shares (option exercise)
- 4 Exercise or conversion Chief Scientific Officer acquired 16,250 shares (option exercise)
- 4 Open-market buy Chief Scientific Officer bought 92,796 shares at an average $2.45 ($227,259)
- 4 Exercise or conversion Director acquired 10,133 shares (option exercise)
- 4 Exercise or conversion Director acquired 12,336 shares (option exercise)
- 4 Exercise or conversion Director acquired 10,133 shares (option exercise)
- 4 Exercise or conversion Director acquired 10,133 shares (option exercise)
- 4 Exercise or conversion Director acquired 10,133 shares (option exercise)
- 4 Open-market sale SVP Reg. & Quality sold 2,377 shares at $4.15 ($9,865)
- 4 Open-market sale Chief Legal Officer sold 2,259 shares at $4.15 ($9,375)
- 4 Open-market sale President and CEO sold 8,786 shares at $4.21 ($36,990)
- 4 Open-market sale Chief Financial Officer sold 2,343 shares at $4.21 ($9,864)
Page 18 of 36 · 701 filings